The liquid handling business will bring in an important part to the increment strategy of our laboratory unit,” comments Dr. Joachim Kreuzburg, CEO of Sartorius AG
- The Sartorius expansion significance
- Integration process has begun
Sartorius, a leading international process and laboratory technology provider, successfully accomplished its acquisition of the liquid handling business of the Finnish laboratory supplier Biohit Oyj. The dealing had been declared on October 26, 2011.
“I'm pleased that we have closed this acquisition as fast as planned. Our first priority in the consolidation process is to chop-chop offer our customers the entire range of products and services with as is high quality we’re known for, all from a exclusive source.”
With this purchase, Sartorius is pursuing its strategy to expand its product offering for laboratory applications. Mechanical and electronic pipettes are among the types of small instrumentation all but often used in laboratories. Up to now, the company has been offering its customers in this section primarily laboratory balances, laboratory water refining systems, moisture analyzers and consumables for sample preparation. As a result of this accomplishment, the Sartorius laboratory business will represent around one third of the Group’s future sales. The larger Sartorius Biotechnology division supplies products and services for the manufacture of biopharmaceuticals.
“The liquid handling business will make an significant part to the development strategy of our laboratory unit,” comments Dr. Joachim Kreuzburg, CEO of Sartorius AG. “I am proud of that we have closed this acquisition as fast as planned. Our first priority in the integration process is to quickly offer our customers the entire range of products and services with the same high quality we’re known for, all from a single source.”
This news transferred from German Version.
Source: Sartorius
Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG
A Profile of Biohit Liquid Handling Link
